Cipla Health Ltd Revenue and Competitors

Mumbai, India



Total Funding


Employee Data

  • Cipla Health Ltd has 1248 Employees.(i)
  • Cipla Health Ltd grew their employee count by 12% last year.

What Is Cipla Health Ltd?

Cipla Health Ltd. offers a folio of diverse brands, distilled out of innovation and the desire to help consumers attain a state of well being. Nicotex, Cofsils, ActivKids, Prolyte ORS, Mamaxpert, and Maxirich are some of our state-of-the-art products that are aimed at not only the betterment of health but also lifestyle enhancement. With innovation at the fore, Cipla Health started the journey of independent consumer healthcare brand in 2015 and launched brands and products based on thorough market research, driving the company's growth through their individual USPs, and a focus on the end goal - to build a healthy and strong future for the Indian consumers.   As a research-driven and fast-paced start-up, we continuously strive to stay ahead and contribute to the on-going need for quality healthcare and an improved lifestyle with our wellness range trusted by the consumers.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Cipla Health Ltd News

2022-04-20 - Alternative Medicines and Therapies Market May Set New ...

... Cipla (India), Sante Verte Lab (France), Sandoz International GmbH (Germany), Biocon Ltd (India), Dr. Reddy's Laboratories (India), Wright Health Group...

2022-04-20 - Chronic pancreatitis Treatment Market By Type, Application ...

... Merck Sharp & Dohme Corp., Novartis AG, Cipla Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company,...

2022-04-19 - Severe Acute Respiratory Syndrome (SARS) Treatment ...

... Hetero labs Ltd., Cipla Ltd., Cadila healthcare Ltd., Ipca laboratories ... As mentioned by the World Health Organization, it was first...

2019-08-17 - Cipla shareholders approve raising up to Rs 3,000 crore

Drug major Cipla on Saturday said its shareholders have approved a proposal to raise up to Rs 3,000 crore through issuance of equity shares or other securities convertible into equity shares. The move was approved by Cipla’s Board in May 2019. In a regulatory filing, Cipla said 99.68 per cent s ...

2018-01-20 - Cipla completes $550 mn acquisition of two US firms

With this acquisition, Cipla will have more relevance to wholesale and retail customers Pharmaceutical firm Cipla today announced that its UK arm, Cipla (EU) has closed the USD 550 million deal to acquire two US-based firms, InvaGen Pharmaceuticals and Exelan Pharmaceuticals. The acquisition w ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding